Clinical study on methylprednisolone combined with latamoxef in treatment of severe community-acquired pneumonia in children

Xiao-qin CAO,Wen-juan GAO,Yuan-yuan ZHANG,Hai-peng HU,Man XU
DOI: https://doi.org/10.7501/j.issn.1674-5515.2019.04.034
2019-01-01
Abstract:Objective To investigate the clinical efficacy of Methylprednisolone Sodium Succinate for injection combined with Latamoxef Sodium for injection in treatment of severe community-acquired pneumonia in children. Methods Children (80 cases) with severe community-acquired pneumonia in the First Affiliated Hospital of Xi'an Jiaotong University from August 2017 to August2018 were divided into control and treatment groups by random comparison table, and each group had 40 cases. Children in the control group were iv administered with Latamoxef Sodium for injection 40 mg/ (kg·d), twice daily, and intravenous drip for more than30 min. Children in the treatment group were iv administered with Methylprednisolone Sodium Succinate for injection 30 mg/kg on the basis of the control group, and intravenous drip for more than 30 min. Children in two groups were treated for 7 d. After treatment, the clinical efficacy was evaluated, and the clinical symptom remission time, arterial blood gas indexes, and serum inflammatory factors levels in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the treatment group was 92.50%, which was significantly higher than 82.50% in the control group, and there were differences between two groups (P<0.05). After treatment, the time of fever relief, asthma relief, lung rale disappearance and cough disappearance in the treatment group were significantly shorter than those in the control group, and there were differences between two groups (P<0.05). After treatment, SaO2 in two groups were significantly increased, but p CO2 were significantly decreased, and the difference was statistically significant in the same group (P<0.05). After treatment, the arterial blood gas indexes in the treatment group were significantly better than those in the control group, and there were differences between two groups (P<0.05). After treatment, the levels of hs-CRP, TNF-α, and IL-6 in two groups were significantly decreased, and the difference was statistically significant in the same group (P<0.05). After treatment, the levels of serum inflammatory factors in the treatment group were significantly lower than those in the control group, with significant difference between two groups (P<0.05). Conclusion Methylprednisolone Sodium Succinate for injection combined with Latamoxef Sodium for injection has a good clinical effect in treatment of severe community-acquired pneumonia in children, can significantly improve the clinical symptoms and arterial blood gas indexes of children, reduce the levels of serum inflammatory factors, which has a certain clinical application value.
What problem does this paper attempt to address?